Cargando…

The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study

Purpose: To early identify abnormal lesions by applying the (18)F-FDG PET dynamic modeling approach for discharged patients recovering from COVID-19. Methods: Seven discharged COVID-19 patients (COVID-19 group), twelve healthy volunteers (control group 1), and eight cancer patients with normal pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jijin, Liu, Jing, Bi, Lei, Huang, Yiying, Wang, Lu, Zhang, Fanwei, Wang, Ying, Jin, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515694/
https://www.ncbi.nlm.nih.gov/pubmed/36185330
http://dx.doi.org/10.7150/ijms.73801
_version_ 1784798542256144384
author Yao, Jijin
Liu, Jing
Bi, Lei
Huang, Yiying
Wang, Lu
Zhang, Fanwei
Wang, Ying
Jin, Hongjun
author_facet Yao, Jijin
Liu, Jing
Bi, Lei
Huang, Yiying
Wang, Lu
Zhang, Fanwei
Wang, Ying
Jin, Hongjun
author_sort Yao, Jijin
collection PubMed
description Purpose: To early identify abnormal lesions by applying the (18)F-FDG PET dynamic modeling approach for discharged patients recovering from COVID-19. Methods: Seven discharged COVID-19 patients (COVID-19 group), twelve healthy volunteers (control group 1), and eight cancer patients with normal pulmonary function (control group 2) were prospectively enrolled. Control group 1 completed static (18)F-FDG PET/CT only; COVID-19 group and control group 2 completed 60-min dynamic (18)F-FDG PET/CT. Among COVID-19 group and control group 2, the uptake of FDG on the last frame (at 55-60 min) of dynamic scans was used for static analysis. Prior to performing scans, COVID-19 patients provided negative real-time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) of SARS-CoV-2, normal lung functions test, and normal laboratory test. Organ-to-liver standard uptake ratio (OLR, i.e. SUV(max)(evaluated organ)/ SUV(max)(liver)) from conventional static data and Patlak analysis based on the dynamic modeling to calculate the (18)F-FDG net uptake rate constant (K(i)) were performed. Results: Compared to the control groups, COVID-19 patients at two to three months after discharge still maintained significantly higher K(i) values in multiple organs (including lung, bone marrow, lymph nodes, myocardium and liver), although results for regular OLR measurements were normal for all discharged COVID-19 patients. Taking the image of lung as an example, the differences of SUV(max) images between COVID-19 group and control group were hard to distinguish. In contrast, a high (18)F-FDG signal of the lung among the COVID-19 group was observed for K(i) images. Conclusion: The K(i) from (18)F-FDG PET/CT dynamic imaging quantification might contribute to identifying residual lesions for COVID-19 survivors. Trial registration: The trial is registered with ClinicalTrials.gov, number NCT04519255 (IRB-approved number, K52-1).
format Online
Article
Text
id pubmed-9515694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-95156942022-09-29 The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study Yao, Jijin Liu, Jing Bi, Lei Huang, Yiying Wang, Lu Zhang, Fanwei Wang, Ying Jin, Hongjun Int J Med Sci Research Paper Purpose: To early identify abnormal lesions by applying the (18)F-FDG PET dynamic modeling approach for discharged patients recovering from COVID-19. Methods: Seven discharged COVID-19 patients (COVID-19 group), twelve healthy volunteers (control group 1), and eight cancer patients with normal pulmonary function (control group 2) were prospectively enrolled. Control group 1 completed static (18)F-FDG PET/CT only; COVID-19 group and control group 2 completed 60-min dynamic (18)F-FDG PET/CT. Among COVID-19 group and control group 2, the uptake of FDG on the last frame (at 55-60 min) of dynamic scans was used for static analysis. Prior to performing scans, COVID-19 patients provided negative real-time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) of SARS-CoV-2, normal lung functions test, and normal laboratory test. Organ-to-liver standard uptake ratio (OLR, i.e. SUV(max)(evaluated organ)/ SUV(max)(liver)) from conventional static data and Patlak analysis based on the dynamic modeling to calculate the (18)F-FDG net uptake rate constant (K(i)) were performed. Results: Compared to the control groups, COVID-19 patients at two to three months after discharge still maintained significantly higher K(i) values in multiple organs (including lung, bone marrow, lymph nodes, myocardium and liver), although results for regular OLR measurements were normal for all discharged COVID-19 patients. Taking the image of lung as an example, the differences of SUV(max) images between COVID-19 group and control group were hard to distinguish. In contrast, a high (18)F-FDG signal of the lung among the COVID-19 group was observed for K(i) images. Conclusion: The K(i) from (18)F-FDG PET/CT dynamic imaging quantification might contribute to identifying residual lesions for COVID-19 survivors. Trial registration: The trial is registered with ClinicalTrials.gov, number NCT04519255 (IRB-approved number, K52-1). Ivyspring International Publisher 2022-09-06 /pmc/articles/PMC9515694/ /pubmed/36185330 http://dx.doi.org/10.7150/ijms.73801 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Yao, Jijin
Liu, Jing
Bi, Lei
Huang, Yiying
Wang, Lu
Zhang, Fanwei
Wang, Ying
Jin, Hongjun
The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title_full The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title_fullStr The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title_full_unstemmed The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title_short The imaging quantification of multiple organs by dynamic (18)F-FDG PET/CT in discharged COVID-19 patients: A prospective pilot study
title_sort imaging quantification of multiple organs by dynamic (18)f-fdg pet/ct in discharged covid-19 patients: a prospective pilot study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515694/
https://www.ncbi.nlm.nih.gov/pubmed/36185330
http://dx.doi.org/10.7150/ijms.73801
work_keys_str_mv AT yaojijin theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT liujing theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT bilei theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT huangyiying theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT wanglu theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT zhangfanwei theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT wangying theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT jinhongjun theimagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT yaojijin imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT liujing imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT bilei imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT huangyiying imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT wanglu imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT zhangfanwei imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT wangying imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy
AT jinhongjun imagingquantificationofmultipleorgansbydynamic18ffdgpetctindischargedcovid19patientsaprospectivepilotstudy